Jean Lachaine
C.P. 6128, Succursale Centre Ville, H3C 3J7
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma - Canadian perspective.
Journal: Journal of comparative effectiveness research
Published: April 20, 2026
Bridging Perspectives: How Canadian Patients and Caregivers View Quality of Life in Multiple Myeloma Compared to Validated Instruments.
Journal: Current oncology (Toronto, Ont.)
Published: February 12, 2026
Burden of Vitiligo in Canada: Retrospective Analysis of a Canadian Public Claims Database.
Journal: Journal of cutaneous medicine and surgery
Published: January 23, 2025
Genome-wide profiling of circulating microRNAs in adolescent idiopathic scoliosis and their relation to spinal deformity severity, and disease pathophysiology.
Journal: Scientific reports
Published: November 04, 2024
Retrospective database analysis on the demographics and resource utilization of patients with Parkinson's disease in Quebec, Canada.
Journal: Clinical parkinsonism & related disorders
Published: July 30, 2024
Adherence to oral antiretroviral therapy in Canada, 2010-2020.
Journal: AIDS (London, England)
Published: July 07, 2023
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: March 21, 2023
Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada.
Journal: Acta haematologica
Published: February 20, 2023
Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: January 10, 2023
Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: August 08, 2022
Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: July 23, 2022
Last Updated: 09/26/2026